Scientech Research’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Scientech Research's PRAX Position: Q2 2026 in Review
Scientech Research increased its Praxis Precision Medicines (PRAX) stake by 405% in Q2 2026, buying an estimated $858K and bringing the position to 3,378 shares worth $1.13M. The position accounts for 0.92% of the portfolio, ranked #38.
Scientech Research first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Scientech Research held 3,378 shares of Praxis Precision Medicines worth $1.13M as of Q2 2026.
- Scientech Research bought 2,709 Praxis Precision Medicines shares in Q2 2026, an estimated $858K.
- Praxis Precision Medicines made up 0.92% of Scientech Research's portfolio in Q2 2026, its #38 holding.
- Scientech Research first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
- 311 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.